Sales of Morning-After Pill Double

As use of emergency contraceptive grows, controversy continues unabated
By Sophie Goldstein,  Newser Staff
Posted Jul 13, 2007 2:42 PM CDT

Nearly a year after Plan B became available over the counter, sales of the emergency contraception have doubled, the Washington Post reports. Since the FDA approved nonprescription access to the morning-after pill, sales for 2007 are on track to approach $80 million, the manufacturer says. Proponents laud the trend, but conservative groups continue to argue against easier availability.

Only women 18 and older with ID can buy Plan B without a prescription, a restriction one advocate says has "no medical basis," and that poses difficulty for some illegal immigrants. Opponents contend that even that much access is too much; a spokeswoman for a group suing the FDA says the increased use is  "putting women's health at risk." (Read more contraception stories.)

We use cookies. By Clicking "OK" or any content on this site, you agree to allow cookies to be placed. Read more in our privacy policy.
Get the news faster.
Tap to install our app.
X
Install the Newser News app
in two easy steps:
1. Tap in your navigation bar.
2. Tap to Add to Home Screen.

X